tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PCRX Stock Latest News

Pacira BioSciences Reports Strong Q3 Growth Amid Challenges
Company AnnouncementsPacira BioSciences Reports Strong Q3 Growth Amid Challenges
2d ago
PCRX
Pacira BioSciences Reports Strong Q3 2025 Results
PremiumCompany Announcements
Pacira BioSciences Reports Strong Q3 2025 Results
3d ago
PCRX
Pacira reports Q3 EPS 70c, consensus 65c
PremiumThe Fly
Pacira reports Q3 EPS 70c, consensus 65c
3d ago
PCRX
Pacira cuts FY25 revenue view to $725M-$735M from $730M-$750M
PremiumThe Fly
Pacira cuts FY25 revenue view to $725M-$735M from $730M-$750M
3d ago
PCRX
Pacira concludes patient enrollment in Part A of Phase 2 study of PCRX-201
PremiumThe Fly
Pacira concludes patient enrollment in Part A of Phase 2 study of PCRX-201
4d ago
PCRX
Pacira enters exclusive license, collaboration agreement with AmacaThera
PremiumThe FlyPacira enters exclusive license, collaboration agreement with AmacaThera
5d ago
PCRX
Pacira presents updated three-year results of PCRX-201
Premium
The Fly
Pacira presents updated three-year results of PCRX-201
12d ago
PCRX
Pacira (PCRX) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Pacira (PCRX) Q3 Earnings Cheat Sheet
12d ago
PCRX
Pacira’s Pediatric Analgesia Study: A Potential Game-Changer for Postoperative Pain Management
PremiumCompany Announcements
Pacira’s Pediatric Analgesia Study: A Potential Game-Changer for Postoperative Pain Management
13d ago
PCRX
Pacira’s Innovative Study on Knee OA Pain Management: What Investors Need to Know
PremiumCompany Announcements
Pacira’s Innovative Study on Knee OA Pain Management: What Investors Need to Know
13d ago
PCRX
Pacira’s Phase 2 Study: A New Approach to Hip Osteoarthritis Treatment
PremiumCompany Announcements
Pacira’s Phase 2 Study: A New Approach to Hip Osteoarthritis Treatment
13d ago
PCRX
Pacira’s New Osteoarthritis Treatment: A Promising Clinical Study Update
PremiumCompany Announcements
Pacira’s New Osteoarthritis Treatment: A Promising Clinical Study Update
13d ago
PCRX
Pacira’s ZILRETTA Study: A Potential Game-Changer for Osteoarthritis Pain Management
PremiumCompany AnnouncementsPacira’s ZILRETTA Study: A Potential Game-Changer for Osteoarthritis Pain Management
13d ago
PCRX
Pacira’s Promising Study on Iovera° System for Spasticity: A Potential Game-Changer
Premium
Company Announcements
Pacira’s Promising Study on Iovera° System for Spasticity: A Potential Game-Changer
13d ago
PCRX
Pacira filed ANDA with FDA for EXPAREL
Premium
The Fly
Pacira filed ANDA with FDA for EXPAREL
13d ago
PCRX
Pacira notified of abbreviated New Drug Application filing from WhiteOak
PremiumThe Fly
Pacira notified of abbreviated New Drug Application filing from WhiteOak
19d ago
PCRX
Pacira reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Pacira reports inducement grants under Nasdaq listing rule
1M ago
PCRX
Pacira reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Pacira reports inducement grants under Nasdaq listing rule
2M ago
PCRX
Doma Perpetual reports 5.7% stake in Pacira, seeks influence
PremiumThe Fly
Doma Perpetual reports 5.7% stake in Pacira, seeks influence
3M ago
PCRX
Pacira up 4% to $24.71 after activist Doma Perpetual takes stake
PremiumThe FlyPacira up 4% to $24.71 after activist Doma Perpetual takes stake
3M ago
PCRX
Pacira’s Earnings Call Highlights Growth and Strategy
Premium
Company Announcements
Pacira’s Earnings Call Highlights Growth and Strategy
3M ago
PCRX
Optimistic Growth Prospects for Pacira Pharmaceuticals Amidst Recent Challenges
Premium
Ratings
Optimistic Growth Prospects for Pacira Pharmaceuticals Amidst Recent Challenges
3M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >